One year ago, The Medicare Negotiation and Competitive Licensing Act was introduced to increase transparency and allow the government to negotiate drug pricing with manufacturers. Recently, the Senate Finance Committee introduced the Prescription Drug Pricing Reduction Act of 2019 to address the high costs of...

Congress has been closely investigating the problem of skyrocketing prescription drug costs and pricing practices. As a result, pharmaceutical drug manufacturers are ramping up their lobbying efforts this year. Pharmaceutical Research and Manufacturers of America (PhRMA) represents 37 of the countries’ biopharmaceutical research companies and has...